Centessa Pharmaceuticals plc - CNTA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | Avoro Capital Advisors LLC | 9.97% | 14,555,555 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Behzad Aghazadeh | 9.97% | 14,555,555 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | FMR LLC | 12.2% | 10,999,793 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 12.2% | 10,999,793 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | FMR LLC | 9.9% | 8,894,939 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 9.9% | 8,894,939 | View |
| Nov 28, 2025 | SCHEDULE 13D/A | — | 5.0% | — | View |
| Nov 17, 2025 | SCHEDULE 13D/A | — | 6.6% | — | View |
| Nov 14, 2025 | SCHEDULE 13G | Avoro Capital Advisors LLC | 8.06% | 10,808,080 | View |
| Nov 14, 2025 | SCHEDULE 13G | Behzad Aghazadeh | 8.06% | 10,808,080 | View |
| Nov 13, 2025 | SCHEDULE 13G/A | Adage Capital Management, L.P. | 7.48% | 10,035,000 | View |
| Nov 13, 2025 | SCHEDULE 13G/A | Robert Atchinson | 7.48% | 10,035,000 | View |
| Nov 13, 2025 | SCHEDULE 13G/A | Phillip Gross | 7.48% | 10,035,000 | View |
| Nov 05, 2025 | SCHEDULE 13G | FMR LLC | 7.0% | 6,277,243 | View |
| Nov 05, 2025 | SCHEDULE 13G | Abigail P. Johnson | 7.0% | 6,277,243 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.